Martingale Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-1,400
| Closed | -$274K | – | 800 |
|
2023
Q3 | $274K | Hold |
1,400
| – | – | 0.01% | 701 |
|
2023
Q2 | $294K | Hold |
1,400
| – | – | 0.01% | 699 |
|
2023
Q1 | $283K | Sell |
1,400
-395
| -22% | -$79.7K | 0.01% | 717 |
|
2022
Q4 | $391K | Sell |
1,795
-752
| -30% | -$164K | 0.01% | 672 |
|
2022
Q3 | $502K | Sell |
2,547
-53,981
| -95% | -$10.6M | 0.01% | 622 |
|
2022
Q2 | $12.1M | Sell |
56,528
-5,086
| -8% | -$1.09M | 0.22% | 129 |
|
2022
Q1 | $17.5M | Sell |
61,614
-6,586
| -10% | -$1.87M | 0.26% | 131 |
|
2021
Q4 | $25.7M | Sell |
68,200
-7,000
| -9% | -$2.64M | 0.33% | 116 |
|
2021
Q3 | $31M | Sell |
75,200
-16,013
| -18% | -$6.61M | 0.41% | 100 |
|
2021
Q2 | $33.7M | Buy |
91,213
+4,899
| +6% | +$1.81M | 0.39% | 99 |
|
2021
Q1 | $25M | Buy |
86,314
+4,370
| +5% | +$1.27M | 0.29% | 124 |
|
2020
Q4 | $20.5M | Buy |
81,944
+34,684
| +73% | +$8.67M | 0.23% | 133 |
|
2020
Q3 | $10.7M | Buy |
47,260
+39,655
| +521% | +$8.98M | 0.13% | 163 |
|
2020
Q2 | $1.33M | Buy |
7,605
+2,600
| +52% | +$454K | 0.02% | 659 |
|
2020
Q1 | $633K | Buy |
+5,005
| New | +$633K | 0.01% | 772 |
|